New funding applications
Making an online funding application
Anyone – a patient, a health professional, or a pharmaceutical supplier – can make a funding application to PHARMAC.
COVID-19: The availability of clinical advice on funding applications is reduced while New Zealand is responding to the COVID-19 pandemic.
This may slow our ability to progress funding applications. Applicants will receive notifications from Application Tracker when there is progress.
What is a funding application?
A funding application is a request made to PHARMAC to change the way we fund a medicine. This can be done through either requesting that a new medicine be funded; or by requesting we make changes to the way a medicine is funded (for example, requesting widened access to the medicine).
Most applications are provided by pharmaceutical companies, who have access to the full range of information PHARMAC requires to assess applications.
How do I make a funding application?
Since 30 August 2019, funding applications are made to PHARMAC using the PHARMConnect system. This is an online tool that you can use to submit funding applications.
There are 3 different application forms available to request funding for new medicines, one for suppliers, one for clinicians and one for consumers. We recognise that clinicians and consumers are unlikely to have access to some of the information required for an application, so we've created additional forms in the PHARMConnect system specifically for them.
NOTE: Please use Google Chrome for the PHARMConnect portal. You will not be able to make a funding application using Internet Explorer.
Pharmaceutical suppliers should refer to both the information contained within the PHARMConnect system and the updates Guidelines for funding applications to PHARMAC for guidance on how to submit funding applications.
Checking on the progress of an application
We understand that information on funding applications and our process can be confusing and difficult to navigate.
We have developed an application tracker so you can view information online on the medicines we are currently considering funding.
The new application tracker features a “progress bar” that displays a simple, visual explanation of where an application is in the assessment process and what happens next.
The application tracker details the progress of applications received since 2008, and of all but a small number of applications since 2002.
PHARMAC uses a range of purchasing strategies to enable the best value to be obtained from the pharmaceutical budget.
Reference pricing means that all pharmaceuticals in any given therapeutic sub-group, to which PHARMAC decides to apply reference pricing, are subsidised at the level of the lowest priced pharmaceutical in that sub-group. Reference pricing is based on the classification of pharmaceuticals into different therapeutic groups and further into sub-groups.
A therapeutic group is defined as a set of pharmaceuticals which are used to treat the same or similar condition(s). A therapeutic sub-group is defined as a set of pharmaceuticals which produce the same or similar therapeutic effect in treating the same or similar condition(s).
PHARMAC uses a Tender to negotiate sole-supply contracts for off-patent pharmaceuticals. This involves issuing tender documents to pharmaceutical suppliers inviting their bids for a set list of pharmaceuticals. Usually the Tender awards three-year sole supply contracts to successful bidders.
Nearly a third of the approximately 1700 formulations listed on the Pharmaceutical Schedule are sourced through the Tender.
Caps and rebates
Contracts with suppliers will sometimes include an agreement to cap expenditure at a certain level, with the supplier agreeing to reimburse the cost of the pharmaceutical in excess of the cap in the form of rebates to PHARMAC.
Product change notifications
Last updated: 6 April 2020